Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The International Transporter Consortium: Summarizing Advances in the Role of Transporters in Drug Development

23 Aug 2018

Abstract excerpt

The past few years have ushered in a wealth of new information on transporter biology, ranging from the publication of new crystal structures of the human glucose transporters (SLC2A2)1 to the discovery of the mechanism by which the monocarboxylate transporter (SLC16A11) associates with type 2 diabetes,2 to a plethora of new therapies that target transporters in the treatment of both common and rare diseases....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Enzymes and Metabolism
Share to Drug Transport and Resistance Mechanisms
Share to HIV/AIDS drug development and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30137696
DOI: 10.1002/cpt.1224

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The International Transporter Consortium: Summarizing Advances in the Role of Transporters in Drug DevelopmentPMID 30137696Read ↗

Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter ConsortiumSemantic proximity Read ↗

Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.Semantic proximity Read ↗

The ABCs of membrane transporters in health and disease (SLC series): IntroductionSemantic proximity Read ↗

Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC PerspectiveSemantic proximity Read ↗

Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.Semantic proximity Read ↗

Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.Semantic proximity Read ↗

International Transporter Consortium Commentary on Clinically Important Transporter PolymorphismsSemantic proximity Read ↗

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.Semantic proximity Read ↗

Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.Semantic proximity Read ↗

[The pharmacogenomics of drug transporters: functional analysis approaches].Semantic proximity Read ↗

Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter ConsortiumSemantic proximity Read ↗

Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.